欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6751/003
药品名称Sitagliptin Glenmark
活性成分
    • SITAGLIPTIN hydrochloride 108.95 mg
剂型Film-coated tablet
上市许可持有人Glenmark Pharmaceuticals s.r.o. Hvezdova 1716/2B 140 78 Prague 4 Czech Republic
参考成员国 - 产品名称Germany (DE)
Sitagliptin Glenmark 100 mg Filmtabletten
互认成员国 - 产品名称
    • Finland (FI)
    • Czechia (CZ)
      Sitagliptin Glenmark
    • Slovakia (SK)
      Sitagliptin Glenmark 100 mg
    • Denmark (DK)
    • Spain (ES)
    • Sweden (SE)
    • Norway (NO)
      Sitagliptin Glenmark
许可日期2021/08/11
最近更新日期2024/01/08
药物ATC编码
    • A10BH01 sitagliptin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase